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ABSTRACT
Genetic and environmental factors may lead to
abnormal growth of the orofacial skeleton. In the
current study, we investigated the craniofacial ab-
normalities in a mouse model for Keutel syndrome
(KS), a genetic disease caused by loss-of-function
mutations in thematrix Gla protein (MGP) gene. KS
patients show ectopic calcification of cartilaginous
tissues and impaired midface development. Our
comparative cephalometric analyses revealed a se-
vere midface hypoplasia in Mgp-/- mice. In vivo re-
porter studies demonstrated that the Mgp promoter
is highly active at the cranial sutures, cranial base
synchondroses and nasal septum. Interestingly, the
cranial sutures of the mutant mice appeared nor-
mal, and although we observed a mild increase of
mineralization at the spheno-occipital synchondro-
sis, it did not reduce the relative length of the cra-
nial base. Contrary to this, we found the nasal sep-
tum to be abnormally mineralized (calcified) and
shortened in Mgp-/- mice. Transgenic restoration
of Mgp expression in chondrocytes prevented nasal
septum calcification and corrected the craniofacial
anomalies caused by MGP deficiency, suggesting a
local role for MGP in midface development. Al-
though there was no upregulation of markers for
hypertrophic chondrocytes, TUNEL assay showed
a marked increase of apoptotic chondrocytes in the
calcified nasal septum. Of note, systemic reduc-
tion of inorganic phosphate level was sufficient to
prevent abnormal mineralization of the nasal sep-
tum in Mgp-/-;Hyp compound mutants. Our work
provides evidence that modulation of local and sys-
temic factors regulating ECM mineralization can be
possible therapeutic strategies to prevent ectopic car-
tilage mineralization and some forms of congenital
craniofacial anomalies in humans.
Congenital anomalies or birth defects are a
major cause of perinatal lethality, affecting 2-3% of
all newborns (1). A significant number of these in-
fants show abnormal craniofacial development that
often disrupts the overall body functions and may
lead to long-term disabilities (1). Both genetic and
epigenetic factors regulating the concerted morpho-
genesis of two craniofacial tissues, bone and carti-
lage, may affect the craniofacial growth and pattern-
ing. Although the primary causes are genetic, ma-
ternal exposure to toxic substances and nutritional
status during pregnancy may also lead to these in-
born deformities (2–6).
Midface hypoplasia is a developmental
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MGP-deficiency impairs craniofacial development
anomaly in which the nasal, maxillary and zygo-
matic bones in the cheek grow slower than other
facial structures (7). Genetic mutations, epigenetic
factors or traumatic injuries during the early stage
of life may lead to midface hypoplasia (8–11). A
mild form of this disorder is usually considered as a
harmless developmental anomaly of the face, while
a severe form may seriously affect health and well-
being. Clinical complications associated with this
disease may include sleep apnea, misalignment of
the jaws and eyelids, dental malocclusion, chew-
ing and swallowing difficulties, impaired speech and
overall disfigurement of the face (12–14) .
Multiple genetic mutations have been asso-
ciated with craniofacial malformations with severely
impaired midface development. For instance, au-
tosomal dominant mutations affecting fibroblast
growth factor signaling cause midface hypoplasia
in several diseases including Pfeiffer syndrome,
Crouzon syndrome and Apert syndrome (8, 15, 16).
In these diseases, the primary cause of midface
abnormalities is the early fusion of the cranial su-
tures (craniosynostosis), which is generally associ-
ated with the premature closure of the cranial base
synchondroses (17, 18).
Although the above developmental anoma-
lies are commonly associated with midface hypopla-
sia, some rare forms of this disease may have a dif-
ferent etiology that is not yet elucidated. For exam-
ple, children born to mothers treated with warfarin
during pregnancy develop Warfarin embryopathy, a
disease characterized mainly by brain haemorrhages
and severe midface hypoplasia (6, 9, 19).
Warfarin is a commonly prescribed anti-
coagulant that inhibits vitamin K epoxide-reductase
(VKORC1), which converts the oxidized form of
vitamin K1 to its reduced form. The reduced vi-
tamin K1 acts as a co-factor for γ-glutamyl car-
boxylase (GGCX) that is essential for the post-
translational gamma-carboxylation of specific glu-
tamic acid residues (Gla) in proteins, collectively
known as "Gla proteins"(20). Similarly, patients
with mutations in matrix Gla protein (MGP) develop
Keutel syndrome, a rare genetic disorder primar-
ily characterized by abnormal mineralization (cal-
cification) of all cartilaginous tissues, short stature,
stocky distal phalanges, arterial calcification and se-
vere midface hypoplasia (3, 21).
MGP and a related protein, osteocalcin
(bone Gla protein, encoded by Bglap), are known as
skeletal Gla proteins (22). While Bglap is expressed
specifically by bone-forming osteoblasts,Mgp is ex-
pressed at high levels by chondrocytes in cartilagi-
nous tissues, vascular smoothmuscle cells (VSMCs)
in the cardiovascular system and by the endothelial-
like cells of the trabecular meshwork (TM) of the eye
(23, 24). Although initially, both of these proteins
were proposed to be potent inhibitors of extracellu-
lar matrix (ECM) mineralization, our previous work
demonstrated that only MGP possesses these anti-
mineralization functions (22).
MGP-deficient mice (Mgp-/- mice) recapit-
ulate most of the phenotypic abnormalities of Keutel
syndrome patients, including as recently reported,
ectopic arterial calcification (25). However, this lat-
ter phenotype is more severe in themousemodel and
represents its primary cause of death (26). Although
MGP-deficient mice have been well-characterized
for their vascular calcification phenotype, their cran-
iofacial anomalies are still understudied.
In the current study, we show that the mid-
face hypoplasia in MGP-deficient mice is primarily
caused by the impaired growth of the maxillary and
palatine bones associated with abnormal mineraliza-
tion and shortening of the nasal septum. For the first
time, we show the activity of the Mgp promoter in
the craniofacial complex using an in vivo reporter
model, and we demonstrate that septal chondrocytes
undergo apoptosis in the absence of MGP. Addi-
tionally, we show a novel mechanism of cartilage
mineralization that, unlike the endochondral bones,
does not require differentiated hypertrophic chon-
drocytes. Also of importance, we demonstrate that
the extent of ectopic nasal septum mineralization in
MGP-deficiency is phosphate-dependant, where re-
duction of systemic phosphate levels impedes nasal
septum mineralization, preventing craniofacial mal-
formations. Considering their phenotypic similari-
ties to human patients, MGP-deficient mice may be
a useful tool to understand the pathology and under-
lying cause of Keutel Syndrome.
RESULTS
MGP deficiency causes midface hypopla-
sia. In order to investigate the effects of MGP and
osteocalcin (BGLAP) deficiency in craniofacial de-
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velopment, the images of lateral and frontal heads of
5-week-old male wild type (WT),Mgp-/- and Bglap-
/-micewere visually examined for gross craniofacial
abnormalities. Mgp-/- mice showed a severe blunt-
ing of the snout and a more rounded and wider face,
whereas the Bglap-/- mice were indistinguishable
from WT mice, as demonstrated by the superimpo-
sition of the facial profiles presented in the lateral
and frontal images (Figure 1A-C). Lateral cephalic
X-rays of age- and gender-matched WT,Mgp-/- and
Bglap-/-mice revealed a severe dental malocclusion
characterized by an anterior crossbite only inMgp-/-
mice; this phenotype was consistent in all the Mgp-
null mice analyzed. Additionally, we detected an
intense radiopaque area above the upper incisors in
Mgp-/- mice, which was not present in Bglap-/- or
WT mice (Figure 1D, asterisk and arrow, respec-
tively). 3D reconstruction of micro-CT scans of the
craniofacial complex of WT and Mgp-/- mice con-
firmed the presence of a severe class IIImalocclusion
(overbite) in the mutant mice (Figure 1E). Consid-
ering the absence of any craniofacial phenotype in
Bglap-/- mice, we conclude that of these two skele-
tal Gla proteins, only MGP is essential for normal
craniofacial development.
We then performed a detailed cephalomet-
ric analysis and found that the maxillary and pala-
tine lengths were more severely affected than other
craniofacial structures in the Mgp-/- mice. In con-
trast, the skull height, anterior cranial height and
inter-molar maxillary distance were not affected,
while only modest decreases were observed in the
mandibular measurements (Figure 2A and B and
SupplementalTable S1). Taken together, these data
identifymidface hypoplasia as themajor craniofacial
phenotype in MGP-deficient mice.
Ectopic calcification of the cartilaginous
nasal septum in MGP-deficient mice. The afore-
mentioned phenotype called for an understanding of
the mechanism by which MGP could affect cranio-
facial development. As a first step in addressing this
question, we studied Mgp expression in the cran-
iofacial complex. To that end, we used a ‘knock
in’ model (Mgp-Cre) in which a Cre recombinase
gene has been inserted at the Mgp locus after the
stop codon (24). These mice were crossed with a
reporter transgenic line, Gtrosa6tm1Sor, carrying a
ubiquitous Rosa promoter followed by a ’floxed’ in-
sulator sequence and the bacterial β-galactosidase
gene. In the resultant compound mutants Mgp-
Cre;Gtrosa6tm1Sor (referred to hereafter as Mgp-
Cre;LacZ), the β-galactosidase gene is expressed in
tissues where the Mgp promoter is active (24). The
whole-mount and dissected heads from 2-week-old
WT and Mgp-Cre;LacZ mice were stained with X-
gal for β-galactosidase activity. Intense blue stain-
ing revealedMgp promoter expression in all the cra-
nial sutures, more strongly in the lambdoidal and
frontonasal sutures (Figure 3A). Also, intense β-
galactosidase activity was detected in the spheno-
occipital synchondrosis (SOS), intersphenoidal syn-
chondrosis (ISS) and in the cartilaginous nasal sep-
tum (NS) of the Mgp-Cre;LacZ mice (Figure 3B).
The lambdoidal, coronal, frontonasal and
palatomaxillary sutures were analyzed using 2D
micro-CT images, which failed to detect any sign
of craniosynostosis or other anomalies in the sutures
of Mgp-/- mice (Figure 3C). Similarly,2D-imaging
of micro-CT scans of the SOS and ISS (top panel,
sagittal view; lower panel, frontal view) did not de-
tect premature closure of the ISS in these mice.
However, at 5 week of age, the SOS appeared to
be disorganized with an aberrant pattern of mineral-
ization (Figure 3D).
Considering our X-ray analysis showing in-
creased radiopacity in the region corresponding to
the nasal septum and the very high expression of
Mgp promoter in this tissue, we examined its min-
eralization status in 5-week-old MGP-deficient mice
by micro-CT. As presented in Figure 3E, frontal
sections detected a striking ectopic mineralization
of the nasal septum, which normally remains un-
mineralized throughout life (27).
Von Kossa and van Gieson (VKVG) stain-
ing of histological sections showed that although not
calcified at birth, by the first week of life, mineral
deposition is already detectable in the septal carti-
lage of MGP-deficient mice. Mineral accumulation
then progressively increases as shown by the analy-
ses of septal cartilage of 2- and 5-week-old mutant
mice, whereas it remains unmineralized in the WT
littermates (Figure 4).
Local expression of Mgp in the cartilage
corrects the midface hypoplasia in MGP-deficient
mice. Wenext investigated whether the local expres-
sion of Mgp in chondrocytes is sufficient to correct
3
 at U
niversity of N
orth Carolina at Chapel H
ill on A
ugust 16, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
MGP-deficiency impairs craniofacial development
the midface hypoplasia in Mgp-/- mice. For this
purpose, we generated two transgenic lines that ex-
pressed Mgp under the Col2a1 promoter (Figure
5A, top panel). Semi-quantitative PCR analyses
showed higher level of transgene expression in the
rib cartilage of one of these founders, although a
weak expression of the transgene was also detected
in the aorta (Figure 5A, lower panel). This ob-
servation was further confirmed by quantitative real
time PCR (qRT-PCR) (Figure 5B). We mated the
Col2a1-Mgp mice with Mgp+/- mice to eventually
generate Mgp-/-,Col2a1-Mgp mice in the F2 gen-
eration. These mice showed approximately a 6-fold
increase ofMgp expression in the nasal septumwhen
compared to the WT littermates (Figure 5C).
In order to examine whether the relative
weak expression ofMgp transgene in the aorta could
prevent arterial calcification, we performed alizarin
red staining of the thoracic skeleton and vascular tis-
sues of 5-week-old WT,Mgp-/- andMgp-/-;Col2a1-
Mgp littermates. We confirmed that the weak ex-
pression of the transgene in Mgp-/-;Col2a1-Mgp
mice was not sufficient to correct the vascular cal-
cification phenotype, suggesting that this is a valid
model for our experiments (Figure 5D).
We next studied the mineralization status
of the nasal septum in Mgp-/-;Col2a1-Mgp mice.
Histological analyses revealed a complete absence
of ectopic mineralization in the septal cartilage. In
contrast, the nasal septum of the Mgp-/- littermates
were severely mineralized (Figure 5E). Cephalic X-
ray imaging of the Mgp-/-;Col2a1-Mgp mice were
comparable to that of theWT littermates, confirming
a complete correction of the dental and skeletal mal-
occlusion (Figure 5F). Similarly, the cranial, maxil-
lary and palatine lengths that were affected inMgp-/-
mice, were normalized in the Mgp-/-;Col2a1-Mgp
mice (Figure 5G). Taken together, these data sug-
gest that local expression of MGP by chondrocytes
can correct the midface hypoplasia in Mgp-/- mice.
MGP-deficient mice have a shorter nasal
septum with apoptotic chondrocytes. We next ex-
amined the effects of Mgp ablation on the growth
of the nasal septum. The exposed septal carti-
lages of WT and Mgp-/- littermates were stained
with Safranin O, and the longitudinal lengths were
measured. There was a significant reduction in the
length of the nasal septum of Mgp-/- mice (Figure
6A). We then analyzed 2Dmicro-CT images to mea-
sure the rostral, basicranial and total skull lengths in
WT and Mgp-/- mice following previously deter-
mined landmarks (28) (Figure 6B, left panel and
Supplemental Table S2).The rostral (point 1-2) and
basicranial (point 2-3, 3-4 and 4-5) lengths were
measured and individually normalized by the to-
tal cranial length (point 1-5). We found that the
rostral segment, but none of the basicranial lengths
measured, were shorter in Mgp-/- mice (Figure 6B,
right panel). This result further suggests that the
shortening of the nasal septum is the cause of the
hypoplastic maxilla in Mgp-/- mice.
In order to understand the cause of nasal
septum shortening inMgp-/- mice, we first assessed
the cell size by calculating the average chondrocyte
area. We did not observe any difference betweenWT
andMgp-/- septal chondrocytes (Figure 7A). Then,
we evaluated chondrocyte proliferation and apopto-
sis. Anti-Ki67 immunostaining showed a compara-
ble cell proliferation rate between WT and Mgp-/-
nasal septum chondrocytes (Figure 7B). However,
we observed an increase of TUNEL positive imma-
ture chondrocytes in the calcified nasal septum of
Mgp-/- mice (Figure 7C).
Chondrocyte hypertrophy is not a prerequi-
site for nasal septum calcification inMGP-deficient
mice. We afterwards interrogated whether ectopic
nasal septum calcification in Mgp-/- mice is analo-
gous to growth plate cartilagemineralization, a phys-
iologic event that occurs during endochondral bone
development. First, we compared the expression of a
general chondrogenic marker Col2a1 (encodes type
II collagen) in the nasal septum of 1-week-old WT
andMgp-/-mice; there was no detectable difference
in mRNA levels (Figure 8A). Similarly, there was a
comparable deposition of type II collagen as evident
by immunostaining of the histological sections of
the septal cartilage from 2-week-oldWT andMgp-/-
mice (Figure 8B). Interestingly, although the carti-
laginous ECM was mineralized, there was no up-
regulation of the hypertrophic chondrocyte marker
Col10a1 by qRT-PCR analysis, nor was there any
alteration of the encoded protein type X collagen
when analyzed by immunostaining (Figure 8C and
8D). Also, we did not detect any increase of alka-
line phosphatase activity, a hallmark of chondrocyte
hypertrophy, in the tissue extracts or histological
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sections prepared from Mgp-/- septal cartilage in
comparison to that of WT cartilage (Figure 8E and
8F).
Amorphous calciumphosphate as a promi-
nent mineral species in MGP-deficient nasal sep-
tum. Ultrastructural analysis of Mgp-/- calcified
nasal septa by transmission electron microscopy
showed globular structures in the ECM, in the vicin-
ity of the chondrocytes. We observed incremental
growth lines at the peripheral regions of the de-
posited mineral (Figure 9A). Detailed characteri-
zation of the mineral deposits by energy-dispersive
X-ray spectroscopy identified them to contain abun-
dant calcium and phosphorus (Figure 9B). X-ray
diffraction (Figure 9C) and electron diffraction (in-
set in Figure 9C) revealed that the inorganic min-
eral present in the MGP-deficient nasal septa was
primarily an amorphous calcium-phosphate phase,
with a slight degree of crystallization towards an ap-
atitic mineral phase as demonstrated by diffraction
rings/spectra labelled 1 and 2 (Figure 9C). It was
also noted that matrix vesicles which are normally
present in the mineralizing growth plates, were gen-
erally not observed in the calcified nasal septum.
Prevention of nasal septum mineralization
inMgp-/-;Hypmice. In order to understandwhether
ectopic mineralization in the nasal septum is regu-
lated by global mechanisms that control bone and
cartilage mineralization, we generated Mgp-/-;Hyp
compound mutants. Hyp mice show an approxi-
mately 50% reduction of phosphate levels in the
serum, with poor bone and tooth mineralization,
largely being attributable to this low level of cir-
culating phosphate, otherwise required for appro-
priate mineralization of the skeleton and dentition
(29). As we reported previously, the systemic reduc-
tion of phosphate level persists inMgp-/-;Hypmice,
while the serum calcium level was not affected (30)
(Figure 10A). We performed 3D micro-CT on 5-
week-old WT,Mgp-/- andMgp-/-;Hyp heads, which
revealed a complete absence of cartilaginous nasal
septummineralization in the doublemutants (Figure
10B). These findings were further confirmed by his-
tology of nasal septum sections demonstrating a
complete absence of mineralized ECM in Mgp-/-
;Hypmice (Figure 10C). Interestingly, there was no
TUNEL-positive nuclei detected on the septal sec-
tions of Mgp-/-;Hyp mice (Figure 10D). Cephalo-
metric analyses of micro-CT images showed a cor-
rection of the class III malocclusion, together with a
normal maxillary and palatine lengths (Figure 10E
and F). Although there was a significant increase of
the cranial length inMgp-/-;Hypmice in comparison
toMgp-/- mice, it remained shorter when compared
to that of WT mice (Figure 10F).
DISCUSSION
Cephalometric analyses of Mgp-/- heads at
5-week-old revealed severe midface abnormalities.
Until now, these abnormalities were not fully char-
acterized and the underlying cause of this phenotype
was unknown. Interestingly, the facial morphology
of this mouse model closely resembles that of Keu-
tel syndrome and Warfarin embryopathy patients,
which justifies a thorough mechanistic study of this
pathology.
Our micro-CT analyses clearly identified
the key features of the facial phenotype in MGP-
deficient mice. These measurements suggest that
overall; the craniofacial bones are undersized in the
mutant mice, which is expected considering their
stunted growth. However, the maxilla and pala-
tine bones are disproportionately smaller affecting
the overall anteroposterior length. Taken together,
the cephalometric analyses confirm that midface hy-
poplasia is the major cause of craniofacial defects in
MGP-deficient mice.
As evident in the published literature, the
two major causes of midface hypoplasia are prema-
ture cranial base synchondroses fusion, and cran-
iosynostosis – premature closure of the cranial vault
sutures (17). It is now believed that the sutures play
a passive role during the growth of the craniofacial
complex, whereas the synchondroses act as growth
centers, providing sites for rapid bone growth until
fusion. Particularly, the spheno-occipital synchon-
drosis has been shown to play a major role as its
late ossification and the closure timing correlates
with the severity of the midface hypoplasia seen in
syndromic patients (17, 28, 31, 32).
Impaired vitamin K metabolism has also
been associated with midface hypoplasia. For
instance, inactivating mutations in the gene for
VKORC1, which generates the reduced form of vi-
tamin K1, and GGCX, which uses it as a co-factor,
both lead to Vitamin K-dependent clotting factor de-
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ficiency and midface hypoplasia (33, 34). Similarly,
babies born to mothers under anticoagulation ther-
apy with warfarin suffer from Warfarin embryopa-
thy, also showing midface abnormalities (6). Con-
sidering that GGCX/VKORC1mutations or fetal ex-
posure to warfarin both affect gamma carboxylation
of Gla proteins, it is expected that these conditions
would lead to the inactivation of the skeletal Gla pro-
teins, e.g. MGP and osteocalcin. However, our ex-
perimental data presented here show that only MGP,
but not osteocalcin deficiency causes midface hy-
poplasia in mice.
The role of the nasal septum in midface de-
velopment has been a matter of controversy for over
half a century. Scott, in 1951, proposed that the
nasal septum, as all other primary cartilages, acts
as a growth center, separating the facial structures
allowing the sagittal growth of the face (35). This
observation was supported by the findings that the
nasal septum responds to hormones and growth fac-
tors and has an intrinsic ability to grow. Addition-
ally, extirpation of the nasal septum has been shown
to impair midface development in rats and rabbits
(10, 36). However, such experimental approaches
were criticized as facial development is slower in
humans than in the animal models used; thus, the
observed midface malformations were attributed to
the surgical trauma.
In 1968, Moss proposed the nasal septum as
a passive structure that serves a supportive role for
the other craniofacial structures (37). This notion
was challenged by in vitro and in vivo studies show-
ing that the intrinsic growth capacity of the nasal
septum is comparable to that of epiphyseal carti-
lages (38, 39). Furthermore, the early corrections
of nasal septum deformities in infants with cleft lips
and palates or other facial defects show a greater
effect on the correction of the overall craniofacial ir-
regularities (40). In agreement with these findings,
we provide evidence that during the early phases of
facial development, ectopic nasal septum mineral-
ization affects the growth of the midface. We report
here that the prevention of nasal septum mineraliza-
tion by transgenic expression ofMgp or by systemic
reduction of inorganic phosphate levels both cor-
rected the midface abnormalities in MGP-deficient
mice. These data support the original theory pro-
posed by Scott that nasal septum acts as a critical
growth element during facial development.
We performed an in vivo reporter assay to
determine Mgp promoter activity in the developing
craniofacial complex. For this purpose, we used
a Cre transgenic line in which the gene encoding
Cre recombinase was ‘knocked in’ at theMgp locus
by placing it directly under the control of the en-
dogenousMgp promoter and its regulatory elements.
Crossing thismodelwith theR26R-lacZ reporter line
enabled us to faithfully establish endogenous Mgp
expression by following β-galactosidase activity in
the resultant offspring (24). The ‘knock in’ strat-
egy we used is superior to the conventional trans-
genic approach as the reporter gene expression is not
driven by a truncated promoter at a random location
in the genome, but by the single copy-endogenous
promoter with all its proximal and distal regulatory
elements. We found strongMgp promoter activity in
the cranial vault sutures, cranial base synchondroses
and in the nasal septum. However, our reporter as-
say only suggests that the promoter is/was active
in the β-galactosidase-positive tissues, but does not
precisely indicate its time of activity during devel-
opment. Considering that the cartilaginous part of
the nasal septum remains unmineralized throughout
adulthood (27), it is likely thatMgp is constitutively
expressed in this tissue. Collectively, our data from
the in vivo reporter assay and qRT-PCR gene expres-
sion analyses performed at two different time points
(2 and 3 weeks of age, respectively) suggest that this
is indeed the case.
It is interesting to note that despite the high
level of Mgp expression in both SOS and ISS, only
the SOS growth plates in Mgp-/- mice showed mild
mineralization irregularities, while the ISS growth
plates remained unaffected. In addition, the cra-
nial sutures were also not abnormally mineralized in
these mice. The absence of ectopic mineralization at
some of these sites could be explained by the action
of other mineralization inhibitor(s) (41), which may
have differential distributions in various connective
tissues. In fact, inorganic pyrophosphate, a potent
mineralization inhibitor, may provide complemen-
tary anti-mineralization functions in some cartilagi-
nous tissues. This notion is supported by the obser-
vation that the severe articular cartilage mineraliza-
tion caused by impaired pyrophosphate metabolism
is absent in MGP-deficient mice (42, 43).
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Despite the presence of ectopic mineraliza-
tion at the SOS, the proportional length of the cranial
base was not smaller in Mgp-/- skulls. Considering
this observation, it is unlikely that the mild ectopic
mineralization of the SOS significantly contributed
to the disproportionate shortening of the midface.
On the other hand, the relative length of the nasal
septum as well as the viscerocranium were signif-
icantly smaller, suggesting that ectopic mineraliza-
tion of the septal cartilage is the major cause of
midface hypoplasia in MGP-deficient mice.
In order to investigate whether MGP acts
locally to prevent abnormal nasal septum miner-
alization, we generated Mgp-/-;Col2a1-Mgp mice.
Unexpectedly, the Col2a1-Mgp transgene showed a
weak expression in the aorta. This can be explained
by the positional effects of the transgene integration
site in the chromosome alone, or combined effects of
both integration site and copy number of the trans-
gene. However, this weak "leaky" expression of the
transgenewas not sufficient to prevent ectopicminer-
alization of the arteries inMgp-/-;Col2a1-Mgpmice.
Our observation that abnormal nasal septum miner-
alization was fully prevented despite the presence
of mineralized arteries, has two important impli-
cations: firstly, it rules out the possibility that the
calcified blood vessels adjacent to the nasal septum
perichondrium serve as nidi for the observed septal
cartilage calcification; and secondly, in agreement
with our previous findings, it establishes that MGP
acts locally to prevent ectopic calcification (22).
During endochondral bone development,
growth plate cartilage mineralization is a normal
process that requires chondrocyte hypertrophy, hall-
marked by type X collagen expression, and the re-
lease of matrix vesicles. Interestingly, chondrocyte
hypertrophy and matrix vesicles appear not to be a
prerequisite for ectopic mineralization of the carti-
laginous ECM in the nasal septum ofMGP-deficient
mice. This observation suggests that mineral accu-
mulation in the septal cartilage is likely not analo-
gous to growth plate cartilage mineralization, where
terminally differentiated chondrocytes undergo hy-
pertrophy, and matrix vesicles seem to participate in
the initiation ofmineralization (44, 45). We reported
a similar nonchondrogenic ectopic mineralization
event in the arteries of MGP-deficient mice (46).
Based on our observation, we conclude that the ini-
tiation of ECM mineralization in the MGP-deficient
nasal septum does not require cellular differentia-
tion (nor release of abundant matrix vesicles), but
happens spontaneously by calcium phosphate pre-
cipitation. As is the case in blood vessels, whether
any particular ECM protein promotes this mineral
precipitation in the absence of MGP is yet to be
determined.
Our analyses of the deposited mineral in the
calcified nasal septum of MGP-deficient mice indi-
cate that the mineral is primarily amorphous (non-
crystalline) calcium phosphate. This finding indi-
cates that MGP normally influences the early stages
of calcium-phosphate precipitation. Although at this
point it is not knownwhat structural features inMGP
are essential for this function, it may not be solely
attributable to the post-translational γ-carboxylation
of its glutamic acid residues. Our earlier work
showed that osteocalcin, a closely related structural
Gla protein, does not possess any significant anti-
mineralization function (22). In agreementwith this,
we did not observe nasal septum mineralization or
craniofacial abnormalities in osteocalcin-deficient
mice. Recent published in vitro data indicate that
N-terminal serine residues in MGP undergo phos-
phorylation and may facilitate the interaction be-
tween MGP and hydroxyapatite minerals (47). The
in vivo significance of these findings is yet to be de-
termined. Identification of the functional residues
in MGP is essential to understand the mechanism
underlying MGP’s anti-mineralization function.
Vascular smooth muscle cells produce large
amounts of MGP, which prevents mineralization of
the elastic lamina in arterial tissues (46). The vascu-
lar mineralization phenotype in MGP-deficient mice
is fully penetrant and appears at the same time as
the initiation of nasal septum mineralization. This
raises the question as to whether mineral deposition
in the nasal septum is actually within the blood ves-
sels present in the tissue. However, this possibility
can be ruled out by our observation that although the
blood vessels are extensively mineralized in Mgp-/-
;Col2a1-Mgp mice, as is the case in Mgp-/- mice,
there was no detectable presence of mineral deposits
in the septal cartilage of Mgp-/-;Col2a1-Mgp mice.
Furthermore, although vascular calcification is not
reported in most of the Keutel syndrome patients,
midface hypoplasia has always been associated with
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this disease, suggesting that these two phenotypic
traits may not be interrelated.
Our experimental data revealed an increase
in apoptosis in the MGP-deficient septal chondro-
cytes, which may explain, at least in part, the ob-
served shortening of the nasal septum in these mice.
Hayano et al found that augmentedBMP-SMADsig-
nalling leads to apoptosis in the developing nasal car-
tilage through p53 upregulation (48). Additionally,
other laboratories have reported that MGP inhibits
BMP signalling in vascular smooth muscle cells
(49). Therefore, it is possible that MGP-deficiency
in the nasal septum may induce BMP signalling and
cause chondrocyte apoptosis. However, this data
needs to be confirmed experimentally. A second hy-
pothesis that can explain the increased apoptosis in
the nasal septum ofMgp-/-mice is the local increase
of inorganic phosphate in the cartilaginous ECM.
Inorganic phosphate has been shown to be a major
regulator of apoptosis of hypertrophic chondrocytes
in the developing endochondral bones (50). As re-
ported here, we found the presence of amorphous
calcium phosphate precipitates in the calcified nasal
septum. The unstable nature of this transient phase
may allow the minerals to be readily dissolved, in-
creasing the local inorganic phosphate levels induc-
ing apoptosis of the neighbouring cells. In addition
to chondrocytes apoptosis, another possible mecha-
nism that may affect the anteroposterior growth of
the nasal septum is the stiffening of its ECM caused
by ectopic mineral deposition. Future studies on
the mechanical properties of the mineralized septal
cartilage will reveal whether this is indeed the case.
Lastly, we found that systemic regulation of
inorganic phosphate levels in the serum is sufficient
to prevent nasal septum mineralization in Mgp-/-
;Hyp double mutant mice. Mutations in the Phex
gene lead toX-linked hypophosphatemia (Hypmice)
characterized by phosphaturia and increased osteoid
volume. Interestingly, lowering serum phosphate
levels in the Mgp-/- mice also completely prevents
the vascular calcification phenotype, as we reported
previously (30). This finding has a substantial clin-
ical implication in that it demonstrates that nasal
septum mineralization and craniofacial malforma-
tions can be modulated by systemic factors. Future
preventive interventions can be developed based on
this finding.
EXPERIMENTAL PROCEDURES
Mice: The generation of Mgp-/-, Bglap-/-
(Ocn-/-) andMgp-Cre;Gtrosa6tm1Sormice have al-
ready been described (24, 26, 51). All the experi-
ments were performed on mice with C57BL/6 back-
ground. Col2a1-Mgp transgenic mice were gener-
ated by pronuclear injection at the Transgenic Core
Facility at the Goodman Cancer Center of McGill
University following standard techniques. Hypmice
were purchased from Jackson Laboratories. Mgp-/-
;Hyp double mutants were generated through breed-
ing, and only male mice were used for our analyses.
Mice were maintained in a pathogen-free standard
animal facility. Genotypes were determined by PCR
on genomic DNAs isolated from tail biopsies. The
sequences of the primers used for genotyping are
provided upon request.
Skeletal preparation: Skeletal tissues from
adult mice were fixed overnight in 95% ethanol,
stained in 0.015% Alcian Blue dye (Sigma-Aldrich)
in a 1:4 solution of glacial acetic acid and absolute
ethanol for 24 hours. Tissues were then treated with
2% potassium hydroxide for another 24 hours (or un-
til the soft tissues were dissolved) and then stained
by 0.005% Alizarin Red (Sigma-Aldrich) in a 1%
potassium hydroxide solution. Finally, the stained
skeletal tissues were clarified in 1% potassium hy-
droxide / 20% glycerol for 2 days.
Radiography and X-ray micro-computed
tomography (micro-CT): Radiographic analyses of
the mouse heads were performed at the Centre
for Bone and Periodontal Research core facility at
McGill University, with an XPERT X-ray imag-
ing system (Kubtec). Micro-CT scanning of mouse
skulls was performed with a SkyScan model 1072
instrument (SkyScan) set at a resolution of 8.0 µm
and 0.5-mm Al filter. Micro-CT image processing
and analysis was performed with version 2.2f of the
manufacturer’s software (SkyScan). Cephalomet-
ric measurements, sutures and cranial base anal-
yses were done using the software Data Viewer
(SkyScan). The 3D-reconstructions of head scans
were done using the CtAn and CtVol software
(SkyScan).
Cephalometric analysis: Cephalometric
analyses of micro-CT scans of whole heads were
done following the method reported by Eimar, et al
(52). Cephalometric analysis of the basicraniumwas
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done according to the modified method reported by
Laurita, et al (28). Only male mice were used for
the cephalometric and basicranial studies.
Histology and tissue imaging: Mouse
skulls were fixed overnight in 10% formalin, em-
bedded in methyl methacrylate, sectioned (7µm),
and stained by von Kossa and van Gieson (VKVG)
or hematoxylin and eosin for cell size assessment.
For type II (ab21291, Abcam Inc) and type X col-
lagen (a generous gift from Dr. Pierre Moffatt,
Shriners Hospital for Children, Montreal (53)) and
Ki-67 (ab66155Abcam Inc) immunohistochemistry,
7µm-thick paraffin sections of decalcified tissues
were prepared. Hematoxylin (Fisher Diagnostics)
was used for visualization of cell nuclei. Images
were taken using a light microscope (DM200; Le-
icaMicrosystems Inc) with 20X (numerical aperture
of 0.40) and 40X (numerical aperture of 0.65) ob-
jectives. Exposed cartilaginous nasal septa were
stained with Safranin-O (BioShop) and scanned us-
ing an Epson V700 PHOTO scanner. Cell area
(µm2) was measured using PhotoShop (Adobe). All
histological images were captured using a digital
camera (DP72; Olympus Canada Inc), acquired with
DP2-BSW software (XV3.0; Olympus Canada Inc),
and processed using PhotoShop software (Adobe).
TUNEL assay: Terminal deoxynucleotidyl-
transferase-mediated dUTP nick end labeling
(TUNEL) assay was performed using a colorimetric
(Trevigen) or a fluorometric (Promega) kit following
the manufacturer’s instructions. Samples from 2-
and 3-week-old mice were decalcified in 25%EDTA
(Sigma-Aldrich) in PBS and embedded in paraffin to
cut 7 micron sections. Upon labeling, sections were
counterstained with 1% methyl green or H33258
(Sigma-Aldrich). TUNEL-positive cells were visu-
alized using light (DM200; LeicaMicrosystems Inc)
and fluorescence (EVOS FL Cell Imaging System,
ThermoFisher Scientific) microscopes and quanti-
fied using Image-J software from NIH.
Alkaline phosphatase activity assay: Tis-
sue extracts were prepared with 1x Passive Lysis
Buffer (Promega) and total proteins were measured
by theMicroBCAprotein assay (ThermoScientific).
Alkaline phosphatase activity was measured using
ρ-nitrophenyl phosphate substrate (Sigma-Aldrich)
and then normalized by the respective protein con-
centration in the extracts.
X-gal staining: For 5-Bromo-4-Chloro-3-
Indolyl-β-D-Galactopyranoside (X-gal) (BioShop)
staining; mouse heads were dissected and fixed for 5
min in 2% formalin and 0.2% glutaraldehyde in PBS
containing 5mMEGTA and 2mMMgCl2. Fixed tis-
sues were rinsed with PBS containing 2mM MgCl2
and 0.2% IGEPAL® CA 630 and left 4 hours in the
same buffer supplemented with 5mM of K3Fe(CN)6
and 5mM of K4Fe(CN)6.3H2O. Later, the whole
mount heads were stained for 4 hours at 37°C in
25 mg/mL X-gal diluted in the same buffer.
Gene expression analysis: Gene expres-
sion analyses were performed using a quantitative
real-time PCR (qRT-PCR) system (Model 7500; Ap-
plied Biosystems). Total RNA was extracted from
different tissues with TRIZOL reagent (Invitrogen)
and subjected to DNase I (Invitrogen) treatment.
The first-strand cDNA synthesis and qRT-PCR were
performed using a high-capacity cDNA reverse-
transcription kit (Applied Biosystems) and Maxima
SYBR green quantitative PCR master mix (Fermen-
tas), respectively. Relative gene expression was an-
alyzed using SDS software (Applied Biosystems)
using comparative CT and hypoxanthine guanine
phosphoribosyl transferase (Hprt, a housekeeping
gene) expression as an endogenous control. In order
to calculate the delta cycle threshold (∆CT) value,
the mean CT value of the expression of a gene in a
sample was first normalized to the mean CT value of
Hprt expression in that sample. The ∆CT value of
the calibrator sample was subtracted from that of the
sample-of-interest to obtain the ∆∆CT value. The
relative expression was reported as 2−∆∆CT .
Electron microscopy: Ultrastructural char-
acterization was performed by transmission electron
microscopy (TEM). Tissues were fixed with 2% glu-
taraldehyde (Electron Microscopy Sciences) in 0.1
M sodium cacodylate buffer at pH 7.2, followed by
dehydration through a series of graded ethanol dilu-
tions. Samples were embedded in LR White acrylic
resin (Electron Microscopy Sciences). Ultrathin
sections (80nm-thick) were cut using a Leica EM
UC6 ultramicrotome (Leica Microsystems Inc), and
were placed on formvar-coated nickel grids (Elec-
tron Microscopy Sciences) and stained convention-
ally with uranyl acetate and lead citrate (Electron
Microscopy Sciences) for viewing by TEM. A field-
emission FEI Tecnai 12 BioTwin TEM (FEI) was
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used to image the stained sections at 120 kV.
Electron diffraction: Electron diffraction in
the selected-area configuration (SAED) and energy-
dispersive X-ray spectroscopy (EDS) were per-
formed at 200 kV with a FEI Tecnai G2 F20
200 cryo-scanning transmission electron micro-
scope equipped with a Gatan Ultrascan 4000 4k x
4k CCD camera system model 895, and an EDAX
Octane T Ultra W /Apollo XLT2 SDD and TEAM
EDS analysis system (FEI). Samples were as those
used for electron microscopy imaging, but sections
were left unstained.
X-ray diffraction: X-ray diffraction (XRD)
analysis was performed using a D8 Discover diffrac-
tometer (Bruker-AXS Inc) equipped with a copper
X-ray tube (wavelength, 1.54056 Å) and a HI-STAR
general area detector diffraction system mounted on
a vertical θ-θ goniometer (Bruker-AXS Inc). Mea-
surements were run in coupled θ–θ scan in mi-
crobeam analysis mode (50µm X-ray beam spot
size). Samples examined were the same as those
used for electron microscopy, where here the mi-
crotomed LR White plastic block face (from which
TEM sections were obtained) was analyzed directly
in the X-ray beam spot mode.
Statistical analysis: All results are shown
as means ± standard deviations. Statistical analy-
ses were performed by Student’s t test or analysis of
variance (Tukey’s multiple-comparison test) using
GraphPad Prism software. p values are indicated on
the chart when significant.
Study approval: All the animal experiments
were performed according to the animal use protocol
number 7132 approved by the Animal Care Commit-
tee of McGill University.
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MGP-deficiency impairs craniofacial development
FOOTNOTES
Abbreviations used within the article: MGP:Matrix Gla Protein, VKORC1: Vitamin K epoxide-reductase,
GGCX: γ-glutamyl-carboxylase, BGLAP: Bone Gla Protein (osteocalcin), VSMCs: Vascular smoothmuscle
cells, TM: Trabecular meshwork, ECM: Extracellular matrix, NS: Nasal septum, SOS: Spheno-occipital
synchondrosis, ISS: Intersphenoidal synchondrosis, Micro-CT: Micro-computed tomography, 2D: Two-
dimensional, 3D: Three-dimensional, TUNEL: terminal deoxynucleotidyltransferase-mediated dUTP nick
end labeling, qRT-PCR: Quantitative real time PCR, BMP: Bonemorphogenetic protein, TEM: Transmission
electron microscopy.
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MGP-deficiency impairs craniofacial development
Figure 1: Ablation of Mgp, but not Bglap causes craniofacial malformations. A. Lateral cephalic
photographs of WT,Mgp-/- and Bglap-/- mice showing a blunt and shorter snout inMgp-/- mice. B. Frontal
cephalic photographs confirming the abnormal craniofacial phenotype in Mgp-/- mice. C. Superimposition
of the lateral and frontal cephalic photographs showing a comparable facial profile betweenWT and Bglap-/-
mice and a blunt and wider profile in Mgp-/- mice. D. Lateral cephalic X-ray of WT, Mgp-/- and Bglap-/-
mice. Mgp-/- mice show a severe anterior crossbite with a radiopaque nasal structure (red asterisk and
arrow, respectively). E. 3D reconstruction of micro-CT scans of WT andMgp-/-mice confirming the dental
malocclusion and craniofacial deformities in the latter genotype.
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MGP-deficiency impairs craniofacial development
Figure 2: MGP deficiency causes midface hypoplasia. A. Depiction of the selected landmarks for
cephalometric analyses of WT andMgp-/-mice. Red, blue and green lines represent the overall craniofacial,
maxillary andmandibularmeasurements, respectively. Description of each landmark’s anatomical location is
presented in Supplemental Table S1. B.Craniofacial, maxillary andmandibularmeasurements inmillimeters.
Each value represents the mean of 6 mice analyzed for each genotype at 5-week-old. Statistical analysis:
Student’s t test, SD (Standard deviation).
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MGP-deficiency impairs craniofacial development
Figure 3: Ectopic calcification of the cartilaginous nasal septum in MGP-deficient mice. A. and B.
Whole-mount heads of 2-week-oldMgp-Cre;LacZ and control mice were stained with X-gal for bacterial β-
galactosidase detection. Intense blue staining revealedMgp-promoter activity in all the craniofacial sutures,
more intensely in the lambdoidal (Ld) and frontonasal (FN) sutures. The spheno-occipital synchondrosis
(SOS), intersphenoidal synchondrosis (ISS) in the basicranial region and nasal septum (NS) were also
strongly stained (red arrows; n=3 mice for each group). C. 2D images of micro-CT scans of WT andMgp-/-
mice showing the absence of craniosynostosis in the mutant mouse in the lambdoidal, coronal, frontonasal
and palatomaxillary sutures (red arrows, n=6 in each group). D. 2D micro-CT scans (top panels: sagittal
view; lower panels: frontal view) of the basicranium of WT and Mgp-/- mice showing the normal anatomy
of the ISS in the mutant mouse. However, the SOS appeared to be disorganized with an aberrant pattern of
mineralization (n=3 mice in each group). E. 3D reconstruction of WT andMgp-/- heads in the frontal plane
showing a severe nasal septum mineralization in the Mgp-/- mice (red arrow, n=6 mice in each group). All
the analyses were done on 5-week-old mice unless indicated otherwise.
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MGP-deficiency impairs craniofacial development
Figure 4: Progressive ectopic mineralization of MGP-deficient nasal septum. Histological analysis of
Mgp-/- nasal septa by VKVG staining of 7µm-thick plastic sections showing the initiation of pathologic
cartilage mineralization at 1 week of age and its progression until 5 weeks of age (n= 3 mice for each time
point). The last panel represents an unmineralized WT nasal septum at 5 weeks of age stained with VKVG.
Scale bar represents 20µm.
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MGP-deficiency impairs craniofacial development
Figure 5: Local expression of Mgp in the cartilage corrects the midface hypoplasia in MGP-deficient
mice. A. Schematic representation of genetic construct used to generate Col2a1-Mgp transgenic mice
expressing Mgp under the cartilage-specific Col2a1 promoter (top panel). The red arrows represent the
primers used to detect the transgene by PCR. Semi-quantitative PCR showing the tissue-specific expression
of the transgene in 2-week-old Col2a1-Mgp mice (middle panel, 1: Cartilage, 2: Aorta, 3: Calvaria, 4:
Muscle, 5: Brain and 6: Long bone) showing a strong Mgp expression in cartilage and minor expression in
aorta. B. qRT-PCR analysis of transgene expression in the same tissues described in Panel A. C. qRT-PCR
showing approximately 6-fold increased Mgp expression in the nasal septum cartilage of Mgp-/-;Col2a1-
Mgp (Mgp-/-;Tg) mice when compared with the WT littermates. Note the absence of Mgp expression in
the nasal septum of Mgp-/- mice. D. Ribcage skeletal preparations of 5-week-old mice stained with alizarin
red and alcian blue showing the vascular mineralization in Mgp-/- mice and in Mgp-/-;Tg mice. E. VKVG
staining showing a complete absence of mineralization in the nasal septum of Mgp-/-;Tg mice. Scale bar
represents 100µm. F. Lateral cephalic X-ray of WT and Mgp-/-;Tg littermates showing the correction of
the craniofacial and dental phenotypes in the latter model. G. Craniofacial measurements showing the
normalization of the cranial, maxillary and palatine lengths inMgp-/-;Tgmice. Statistical analysis: ANOVA
(Tukey’s multiple-comparison test). All the analyses were done with 5-week-old mice (n=3 in each group
for each experiment).
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MGP-deficiency impairs craniofacial development
Figure 6: MGP-deficient mice have a shorter nasal septum. A. Exposed cartilaginous nasal septa of
5-week-old WT andMgp-/- mice stained with Safranin O. Measurement of the lengths presented as relative
length ratio shows a significantly smaller nasal septum inMgp-/- mice. B. 2D cephalometric analysis of the
viscerocranium and basicranium of 5-week-old WT and Mgp-/- mice. The viscerocranium (1-2) in Mgp-/-
mice is significantly smaller when compared to WT mice, whereas the total basicranial length (2-5) is not
affected. Values represent the ratio of the linear distance between points over the total cranial length (1-5).
Description of the landmark’s anatomical locations is presented in supplemental material Table S2, (n=5 in
both groups). Statistical analysis: Student’s t test in all cases.
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MGP-deficiency impairs craniofacial development
Figure 7: MGP-deficient septal chondrocytes undergo apoptosis. A. Quantification of cell area on
histological sections of WT and Mgp-/- nasal septa stained with hematoxylin and eosin (H&E) shows no
difference in chondrocyte size between the genotypes. Three fields were quantified per sample (n=3 in both
groups). Scale bar represents 20µm. B. Anti-Ki67 antibody and hematoxylin staining of septal sections
showing the proliferating chondrocytes (arrows). Quantification of proliferative cells/total cell count shows
no difference betweenWTandMgp-/-mice (n=6 in both groups). Scale bar represents 20µm. C.Colorimetric
apoptosis detection assay (TUNEL) performed on WT and Mgp-/- septal sections shows the presence of
apoptotic cells (arrow) in the MGP-deficient nasal septum but not in the WT nasal septum sections. The
sections were counter-stained by methyl green (n=3 in both groups). Scale bars represent 20µm. All analyses
were performed on 2-week-old mice; statistical analysis: Student’s t test in all cases.
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MGP-deficiency impairs craniofacial development
Figure 8: Chondrocyte hypertrophy is not a prerequisite for ectopic mineralization of the nasal septum
in MGP-deficient mice. A. Gene expression analysis of Col2a1 in 1-week-old WT and Mgp-/- nasal septa
showing comparable expression in both groups. B. Immunohistochemistry showing similar expression
pattern of type II collagen in 2-week-old WT and Mgp-/- nasal septa. Embryonic humerus growth plate
staining was used as a positive control. C. Col10a1 gene expression in 1-week-old WT and Mgp-/- mice
showing no induction in the ’knockout’ tissue. D. Absence of anti-Type X collagen staining in the WT and
Mgp-/- 2-week-old nasal septum. Embryonic humerus growth plate staining was used as a positive control.
E. The alkaline phosphatase (ALPL) basal activity inMgp-/- nasal septum extracts from 2-week-old mice is
comparable to that of WT littermates. F. ALPL staining confirms the absence of ALPL activity in the septal
cartilage of Mgp-/- mice. Staining of septal growth plate sections from 2-week-old WT mice was used as a
positive control. Scale bars for histological sections represent 40µm. Statistical analysis: Student’s t test in
all cases.
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MGP-deficiency impairs craniofacial development
Figure 9: Amorphous calcium phosphate as main mineral species in MGP-deficient nasal septum. A.
Transmission electron microscopy of 1-week-old Mgp-/- nasal septum showing the presence of chondro-
cytes (Ch), and mineral deposits (asterisks) having an unusual globular shape. Note the incremental lines
(suggesting periodic mineral deposition) within the mineral deposits (arrowheads). B. Energy-dispersive
X-ray spectroscopy showing the presence of phosphorus and calcium within the mineral deposits. C. X-ray
diffraction showing that the mineral phase is largely amorphous calcium phosphate. Minor spectral peaks
labelled 1 and 2 indicate tendencies toward crystallization (initiation) of an apatitic phase. Inset in C. Elec-
tron diffraction pattern confirming the presence of mostly amorphous mineral showing only diffuse (rather
than sharp) electron diffraction rings labelled as 1 and 2 (n=3 mice for each group and each experiment).
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Figure 10: Prevention of nasal septum mineralization in Mgp-/-;Hyp mice. A. Serum calcium and
inorganic phosphate levels in the WT, Mgp-/- and Mgp-/-;Hyp mice show similar calcium levels in all the
genotypes and confirms the presence of hypophosphatemia in the Mgp-/-;Hyp mice. Values are shown
in mg/dl. (n=4). B. 3D reconstruction of micro-CT scans of gender- and age-matched WT, Mgp-/- and
Mgp-/-;Hypmice showing the correction of nasal septum mineralization in the double mutant. C. Histology
of nasal septum of Mgp-/- and Mgp-/-;Hyp mice stained with VKVG confirming the absence of apatitic
minerals in the latter phenotype. Scale bar represents 50µm. D. Fluorometric TUNEL assay shows the
presence of apoptotic immature chondrocytes in 3-week-old Mgp-/- (arrows), but not in Mgp-/-;Hyp nasal
septa. Images of the same field showing fluorescein-12-dUTP (labels fragmented DNA ends) and H33258
(nuclear stain) fluorescence were overlaid to create the combined images. Scale bar represents 25µm. E.
3D reconstruction of micro-CT scans of Mgp-/- and Mgp-/-;Hyp mice. Note the correction of the midface
hypoplasia and class III malocclusion in the compound mutant. F. Cephalometric analysis of WT, Mgp-/-
and age- and gender-matchedMgp-/-;Hypmice showing a complete correction of the palatine and maxillary
lengths in the Mgp-/-;Hyp mice. Although the cranial length is corrected in the Mgp-/-;Hyp mice when
compared to Mgp-/- mice, it remains shorter than the WT controls. All the analyses were performed in
5-week-old mice unless indicated otherwise (n=3 male mice in each group for each experiment). Statistical
analysis: ANOVA (Tukey’s multiple-comparison test).
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